ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dihydropyridine Calcium Channel Blocker Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-22L13028
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Dihydropyridine Calcium Channel Blocker Market Research Report 2023
BUY CHAPTERS

Global Dihydropyridine Calcium Channel Blocker Market Research Report 2025

Code: QYRE-Auto-22L13028
Report
February 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
Abbott
Novartis
Sanofi
Desano
Baiyunshan Pharma
Dawnrays
Sine Promod
Kang Lisheng Pharma
Guo Guang Pharma

Dihydropyridine Calcium Channel Blocker Market Size

The global market for Dihydropyridine Calcium Channel Blocker was valued at US$ 26.9 million in the year 2024 and is projected to reach a revised size of US$ 30.8 million by 2031, growing at a CAGR of 2.0% during the forecast period.

Dihydropyridine Calcium Channel Blocker Market

Dihydropyridine Calcium Channel Blocker Market

Dihydropyridine (DHP) calcium channel blockers are derived from the molecule dihydropyridine and often used to reduce systemic vascular resistance and arterial pressure. Sometimes when they are used to treat angina, the vasodilation and hypotension can lead to reflex tachycardia, which can be detrimental for patients with ischemicsymptoms because of the resulting increase in myocardial oxygen demand. Dihydropyridine calcium channel blockers can worsen proteinuria in patients with nephropathy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dihydropyridine Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydropyridine Calcium Channel Blocker.
The Dihydropyridine Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dihydropyridine Calcium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydropyridine Calcium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dihydropyridine Calcium Channel Blocker Market Report

Report Metric Details
Report Name Dihydropyridine Calcium Channel Blocker Market
Accounted market size in year US$ 26.9 million
Forecasted market size in 2031 US$ 30.8 million
CAGR 2.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Norvasc
  • Plendil
  • DynaCirc
  • Cardene
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, AstraZeneca, Abbott, Novartis, Sanofi, Sine Promod, Desano, Kang Lisheng Pharma, Guo Guang Pharma, Baiyunshan Pharma, Dawnrays
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dihydropyridine Calcium Channel Blocker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dihydropyridine Calcium Channel Blocker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Dihydropyridine Calcium Channel Blocker Market growing?

Ans: The Dihydropyridine Calcium Channel Blocker Market witnessing a CAGR of 2.0% during the forecast period 2025-2031.

What is the Dihydropyridine Calcium Channel Blocker Market size in 2031?

Ans: The Dihydropyridine Calcium Channel Blocker Market size in 2031 will be US$ 30.8 million.

Who are the main players in the Dihydropyridine Calcium Channel Blocker Market report?

Ans: The main players in the Dihydropyridine Calcium Channel Blocker Market are Pfizer, AstraZeneca, Abbott, Novartis, Sanofi, Sine Promod, Desano, Kang Lisheng Pharma, Guo Guang Pharma, Baiyunshan Pharma, Dawnrays

What are the Application segmentation covered in the Dihydropyridine Calcium Channel Blocker Market report?

Ans: The Applications covered in the Dihydropyridine Calcium Channel Blocker Market report are Hypertension, Coronary Artery Disease, Arrhythmia, Cardiomyopathy, Others

What are the Type segmentation covered in the Dihydropyridine Calcium Channel Blocker Market report?

Ans: The Types covered in the Dihydropyridine Calcium Channel Blocker Market report are Norvasc, Plendil, DynaCirc, Cardene, Others

Recommended Reports

Cardiovascular Disease Drugs

Calcium Channel Blockers

Heart & Circulatory Drugs

1 Dihydropyridine Calcium Channel Blocker Market Overview
1.1 Product Definition
1.2 Dihydropyridine Calcium Channel Blocker by Type
1.2.1 Global Dihydropyridine Calcium Channel Blocker Market Value Comparison by Type (2024 VS 2031)
1.2.2 Norvasc
1.2.3 Plendil
1.2.4 DynaCirc
1.2.5 Cardene
1.2.6 Others
1.3 Dihydropyridine Calcium Channel Blocker by Application
1.3.1 Global Dihydropyridine Calcium Channel Blocker Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.3.6 Others
1.4 Global Dihydropyridine Calcium Channel Blocker Market Size Estimates and Forecasts
1.4.1 Global Dihydropyridine Calcium Channel Blocker Revenue 2020-2031
1.4.2 Global Dihydropyridine Calcium Channel Blocker Sales 2020-2031
1.4.3 Global Dihydropyridine Calcium Channel Blocker Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dihydropyridine Calcium Channel Blocker Market Competition by Manufacturers
2.1 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dihydropyridine Calcium Channel Blocker Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dihydropyridine Calcium Channel Blocker, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Product Type & Application
2.7 Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Date of Enter into This Industry
2.8 Global Dihydropyridine Calcium Channel Blocker Market Competitive Situation and Trends
2.8.1 Global Dihydropyridine Calcium Channel Blocker Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dihydropyridine Calcium Channel Blocker Players Market Share by Revenue
2.8.3 Global Dihydropyridine Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dihydropyridine Calcium Channel Blocker Market Scenario by Region
3.1 Global Dihydropyridine Calcium Channel Blocker Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dihydropyridine Calcium Channel Blocker Sales by Region: 2020-2031
3.2.1 Global Dihydropyridine Calcium Channel Blocker Sales by Region: 2020-2025
3.2.2 Global Dihydropyridine Calcium Channel Blocker Sales by Region: 2026-2031
3.3 Global Dihydropyridine Calcium Channel Blocker Revenue by Region: 2020-2031
3.3.1 Global Dihydropyridine Calcium Channel Blocker Revenue by Region: 2020-2025
3.3.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Region: 2026-2031
3.4 North America Dihydropyridine Calcium Channel Blocker Market Facts & Figures by Country
3.4.1 North America Dihydropyridine Calcium Channel Blocker Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2031)
3.4.3 North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dihydropyridine Calcium Channel Blocker Market Facts & Figures by Country
3.5.1 Europe Dihydropyridine Calcium Channel Blocker Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2031)
3.5.3 Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dihydropyridine Calcium Channel Blocker Market Facts & Figures by Region
3.6.1 Asia Pacific Dihydropyridine Calcium Channel Blocker Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2020-2031)
3.6.3 Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dihydropyridine Calcium Channel Blocker Market Facts & Figures by Country
3.7.1 Latin America Dihydropyridine Calcium Channel Blocker Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2031)
3.7.3 Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dihydropyridine Calcium Channel Blocker Market Facts & Figures by Country
3.8.1 Middle East and Africa Dihydropyridine Calcium Channel Blocker Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dihydropyridine Calcium Channel Blocker Sales by Type (2020-2031)
4.1.1 Global Dihydropyridine Calcium Channel Blocker Sales by Type (2020-2025)
4.1.2 Global Dihydropyridine Calcium Channel Blocker Sales by Type (2026-2031)
4.1.3 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2020-2031)
4.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Type (2020-2031)
4.2.1 Global Dihydropyridine Calcium Channel Blocker Revenue by Type (2020-2025)
4.2.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Type (2026-2031)
4.2.3 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2020-2031)
4.3 Global Dihydropyridine Calcium Channel Blocker Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dihydropyridine Calcium Channel Blocker Sales by Application (2020-2031)
5.1.1 Global Dihydropyridine Calcium Channel Blocker Sales by Application (2020-2025)
5.1.2 Global Dihydropyridine Calcium Channel Blocker Sales by Application (2026-2031)
5.1.3 Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2020-2031)
5.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Application (2020-2031)
5.2.1 Global Dihydropyridine Calcium Channel Blocker Revenue by Application (2020-2025)
5.2.2 Global Dihydropyridine Calcium Channel Blocker Revenue by Application (2026-2031)
5.2.3 Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2020-2031)
5.3 Global Dihydropyridine Calcium Channel Blocker Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Dihydropyridine Calcium Channel Blocker Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Dihydropyridine Calcium Channel Blocker Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Dihydropyridine Calcium Channel Blocker Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Dihydropyridine Calcium Channel Blocker Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Dihydropyridine Calcium Channel Blocker Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Sine Promod
6.6.1 Sine Promod Company Information
6.6.2 Sine Promod Description and Business Overview
6.6.3 Sine Promod Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sine Promod Dihydropyridine Calcium Channel Blocker Product Portfolio
6.6.5 Sine Promod Recent Developments/Updates
6.7 Desano
6.7.1 Desano Company Information
6.7.2 Desano Description and Business Overview
6.7.3 Desano Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Desano Dihydropyridine Calcium Channel Blocker Product Portfolio
6.7.5 Desano Recent Developments/Updates
6.8 Kang Lisheng Pharma
6.8.1 Kang Lisheng Pharma Company Information
6.8.2 Kang Lisheng Pharma Description and Business Overview
6.8.3 Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Product Portfolio
6.8.5 Kang Lisheng Pharma Recent Developments/Updates
6.9 Guo Guang Pharma
6.9.1 Guo Guang Pharma Company Information
6.9.2 Guo Guang Pharma Description and Business Overview
6.9.3 Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Product Portfolio
6.9.5 Guo Guang Pharma Recent Developments/Updates
6.10 Baiyunshan Pharma
6.10.1 Baiyunshan Pharma Company Information
6.10.2 Baiyunshan Pharma Description and Business Overview
6.10.3 Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Product Portfolio
6.10.5 Baiyunshan Pharma Recent Developments/Updates
6.11 Dawnrays
6.11.1 Dawnrays Company Information
6.11.2 Dawnrays Description and Business Overview
6.11.3 Dawnrays Dihydropyridine Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dawnrays Dihydropyridine Calcium Channel Blocker Product Portfolio
6.11.5 Dawnrays Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dihydropyridine Calcium Channel Blocker Industry Chain Analysis
7.2 Dihydropyridine Calcium Channel Blocker Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dihydropyridine Calcium Channel Blocker Production Mode & Process Analysis
7.4 Dihydropyridine Calcium Channel Blocker Sales and Marketing
7.4.1 Dihydropyridine Calcium Channel Blocker Sales Channels
7.4.2 Dihydropyridine Calcium Channel Blocker Distributors
7.5 Dihydropyridine Calcium Channel Blocker Customer Analysis
8 Dihydropyridine Calcium Channel Blocker Market Dynamics
8.1 Dihydropyridine Calcium Channel Blocker Industry Trends
8.2 Dihydropyridine Calcium Channel Blocker Market Drivers
8.3 Dihydropyridine Calcium Channel Blocker Market Challenges
8.4 Dihydropyridine Calcium Channel Blocker Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Astrazeneca plc
Abbott
Novartis
Sanofi
Desano
Baiyunshan Pharma
Dawnrays
Sine Promod
Kang Lisheng Pharma
Guo Guang Pharma
List of Tables
 Table 1. Global Dihydropyridine Calcium Channel Blocker Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Dihydropyridine Calcium Channel Blocker Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Dihydropyridine Calcium Channel Blocker Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Dihydropyridine Calcium Channel Blocker Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Dihydropyridine Calcium Channel Blocker Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Dihydropyridine Calcium Channel Blocker Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Dihydropyridine Calcium Channel Blocker, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Product Type & Application
 Table 12. Global Key Manufacturers of Dihydropyridine Calcium Channel Blocker, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dihydropyridine Calcium Channel Blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydropyridine Calcium Channel Blocker as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dihydropyridine Calcium Channel Blocker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Dihydropyridine Calcium Channel Blocker Sales by Region (2020-2025) & (K Units)
 Table 18. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2020-2025)
 Table 19. Global Dihydropyridine Calcium Channel Blocker Sales by Region (2026-2031) & (K Units)
 Table 20. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2026-2031)
 Table 21. Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region (2020-2025)
 Table 23. Global Dihydropyridine Calcium Channel Blocker Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region (2026-2031)
 Table 25. North America Dihydropyridine Calcium Channel Blocker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2025) & (K Units)
 Table 27. North America Dihydropyridine Calcium Channel Blocker Sales by Country (2026-2031) & (K Units)
 Table 28. North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Dihydropyridine Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Dihydropyridine Calcium Channel Blocker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Dihydropyridine Calcium Channel Blocker Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Dihydropyridine Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Dihydropyridine Calcium Channel Blocker Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Dihydropyridine Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Dihydropyridine Calcium Channel Blocker Sales (K Units) by Type (2020-2025)
 Table 51. Global Dihydropyridine Calcium Channel Blocker Sales (K Units) by Type (2026-2031)
 Table 52. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2020-2025)
 Table 53. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Type (2026-2031)
 Table 54. Global Dihydropyridine Calcium Channel Blocker Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Dihydropyridine Calcium Channel Blocker Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2020-2025)
 Table 57. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Type (2026-2031)
 Table 58. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Dihydropyridine Calcium Channel Blocker Sales (K Units) by Application (2020-2025)
 Table 61. Global Dihydropyridine Calcium Channel Blocker Sales (K Units) by Application (2026-2031)
 Table 62. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2020-2025)
 Table 63. Global Dihydropyridine Calcium Channel Blocker Sales Market Share by Application (2026-2031)
 Table 64. Global Dihydropyridine Calcium Channel Blocker Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Dihydropyridine Calcium Channel Blocker Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2020-2025)
 Table 67. Global Dihydropyridine Calcium Channel Blocker Revenue Market Share by Application (2026-2031)
 Table 68. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Dihydropyridine Calcium Channel Blocker Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Dihydropyridine Calcium Channel Blocker Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Dihydropyridine Calcium Channel Blocker Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Dihydropyridine Calcium Channel Blocker Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Dihydropyridine Calcium Channel Blocker Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Sine Promod Company Information
 Table 96. Sine Promod Description and Business Overview
 Table 97. Sine Promod Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sine Promod Dihydropyridine Calcium Channel Blocker Product
 Table 99. Sine Promod Recent Developments/Updates
 Table 100. Desano Company Information
 Table 101. Desano Description and Business Overview
 Table 102. Desano Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Desano Dihydropyridine Calcium Channel Blocker Product
 Table 104. Desano Recent Developments/Updates
 Table 105. Kang Lisheng Pharma Company Information
 Table 106. Kang Lisheng Pharma Description and Business Overview
 Table 107. Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Kang Lisheng Pharma Dihydropyridine Calcium Channel Blocker Product
 Table 109. Kang Lisheng Pharma Recent Developments/Updates
 Table 110. Guo Guang Pharma Company Information
 Table 111. Guo Guang Pharma Description and Business Overview
 Table 112. Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Guo Guang Pharma Dihydropyridine Calcium Channel Blocker Product
 Table 114. Guo Guang Pharma Recent Developments/Updates
 Table 115. Baiyunshan Pharma Company Information
 Table 116. Baiyunshan Pharma Description and Business Overview
 Table 117. Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Baiyunshan Pharma Dihydropyridine Calcium Channel Blocker Product
 Table 119. Baiyunshan Pharma Recent Developments/Updates
 Table 120. Dawnrays Company Information
 Table 121. Dawnrays Description and Business Overview
 Table 122. Dawnrays Dihydropyridine Calcium Channel Blocker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Dawnrays Dihydropyridine Calcium Channel Blocker Product
 Table 124. Dawnrays Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Dihydropyridine Calcium Channel Blocker Distributors List
 Table 128. Dihydropyridine Calcium Channel Blocker Customers List
 Table 129. Dihydropyridine Calcium Channel Blocker Market Trends
 Table 130. Dihydropyridine Calcium Channel Blocker Market Drivers
 Table 131. Dihydropyridine Calcium Channel Blocker Market Challenges
 Table 132. Dihydropyridine Calcium Channel Blocker Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dihydropyridine Calcium Channel Blocker
 Figure 2. Global Dihydropyridine Calcium Channel Blocker Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dihydropyridine Calcium Channel Blocker Market Share by Type: 2024 & 2031
 Figure 4. Norvasc Product Picture
 Figure 5. Plendil Product Picture
 Figure 6. DynaCirc Product Picture
 Figure 7. Cardene Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Dihydropyridine Calcium Channel Blocker Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Dihydropyridine Calcium Channel Blocker Market Share by Application: 2024 & 2031
 Figure 11. Hypertension
 Figure 12. Coronary Artery Disease
 Figure 13. Arrhythmia
 Figure 14. Cardiomyopathy
 Figure 15. Others
 Figure 16. Global Dihydropyridine Calcium Channel Blocker Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Dihydropyridine Calcium Channel Blocker Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Dihydropyridine Calcium Channel Blocker Sales (2020-2031) & (K Units)
 Figure 19. Global Dihydropyridine Calcium Channel Blocker Average Price (US$/Unit) & (2020-2031)
 Figure 20. Dihydropyridine Calcium Channel Blocker Report Years Considered
 Figure 21. Dihydropyridine Calcium Channel Blocker Sales Share by Manufacturers in 2024
 Figure 22. Global Dihydropyridine Calcium Channel Blocker Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Dihydropyridine Calcium Channel Blocker Players: Market Share by Revenue in Dihydropyridine Calcium Channel Blocker in 2024
 Figure 24. Dihydropyridine Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Dihydropyridine Calcium Channel Blocker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Dihydropyridine Calcium Channel Blocker Sales Market Share by Country (2020-2031)
 Figure 27. North America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Country (2020-2031)
 Figure 28. United States Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Dihydropyridine Calcium Channel Blocker Sales Market Share by Country (2020-2031)
 Figure 31. Europe Dihydropyridine Calcium Channel Blocker Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Dihydropyridine Calcium Channel Blocker Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Dihydropyridine Calcium Channel Blocker Revenue Market Share by Region (2020-2031)
 Figure 39. China Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Dihydropyridine Calcium Channel Blocker Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Dihydropyridine Calcium Channel Blocker Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Dihydropyridine Calcium Channel Blocker Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Dihydropyridine Calcium Channel Blocker Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Dihydropyridine Calcium Channel Blocker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Dihydropyridine Calcium Channel Blocker by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Dihydropyridine Calcium Channel Blocker by Type (2020-2031)
 Figure 60. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Dihydropyridine Calcium Channel Blocker by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Dihydropyridine Calcium Channel Blocker by Application (2020-2031)
 Figure 63. Global Dihydropyridine Calcium Channel Blocker Price (US$/Unit) by Application (2020-2031)
 Figure 64. Dihydropyridine Calcium Channel Blocker Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Dihydropyridine DHP Market Research Report 2024
Diltiazem Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diltiazem Calcium Channel Blocker Market Research Report 2025
Global Calcium Channel Blocker Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Amlodipine Besylate Tablets Market Research Report 2024
Global Amlodipine Besilate Market Research Report 2024
Calcium Channel Blockers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amlodipine Market Research Report 2024
Global Verapamil Calcium Channel Blocker Market Research Report 2025
Global Nifedipine Injection Market Research Report 2025
Global Verapamil Market Research Report 2024
Global Nifedipine Medication Market Research Report 2024
Global Calcium Channel Antagonist Market Research Report 2024
Global Nicardipine Hydrochloride Tablets Market Research Report 2025
Global Felodipine Tablets Market Research Report 2025
Global Azelnidipine API Market Research Report 2025
Global Diltiazem Hydrochloride Tablets Market Research Report 2025
Global Diltiazem Hydrochloride Extended Release Tablets Market Research Report 2025
Global Nicardipine Hydrochloride Injection Market Research Report 2024
Global Calcium Antagonists Market Insights Forecast to 2030

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions